Results for tag: "Oncolytic Adenovirus Drug"

The Oncolytic Adenovirus Drug market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Oncolytic Adenovirus Drugs are a type of gene therapy that use a modified form of the adenovirus to target and destroy cancer cells. These drugs are designed to selectively replicate in cancer cells, while leaving healthy cells unharmed. They can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. Oncolytic Adenovirus Drugs have the potential to improve the efficacy of cancer treatments, reduce side effects, and improve patient outcomes. They are currently being studied in clinical trials for a variety of cancers, including lung, breast, and ovarian cancer. Some companies in the Oncolytic Adenovirus Drug market include Amgen, Merck, and Pfizer. Other companies, such as Oncolytics Biotech, are developing oncolytic adenovirus drugs for the treatment of cancer. Show Less Read more